Please select and order
€154.70
excl. VAT
Add to cart
Norm

ISO 10993-1:2018

Issue date: 2018 08 17

Biological evaluation of medical devices — Part 1: Evaluation and testing within a risk management process (Corrected version 2018-10)

This document specifies: — the general principles governing the biological evaluation of medical devices within a risk management process; — the general...
Valid
Publisher:
International Organization for Standardization
Format:
Digital | 41 Pages
Language:
English

This document specifies:

— the general principles governing the biological evaluation of medical devices within a risk management process;

— the general categorization of medical devices based on the nature and duration of their contact with the body;

— the evaluation of existing relevant data from all sources;

— the identification of gaps in the available data set on the basis of a risk analysis;

— the identification of additional data sets necessary to analyse the biological safety of the medical device;

— the assessment of the biological safety of the medical device.

This document applies to evaluation of materials and medical devices that are expected to have direct or indirect contact with:

— the patient's body during intended use;

— the user's body, if the medical device is intended for protection (e.g., surgical gloves, masks and others).

This document is applicable to biological evaluation of all types of medical devices including active, non-active, implantable and non-implantable medical devices.

This document also gives guidelines for the assessment of biological hazards arising from:

— risks, such as changes to the medical device over time, as a part of the overall biological safety assessment;

— breakage of a medical device or medical device component which exposes body tissue to new or novel materials.

Other parts of ISO 10993 cover specific aspects of biological assessments and related tests. Device-specific or product standards address mechanical testing.

This document excludes hazards related to bacteria, moulds, yeasts, viruses, transmissible spongiform encephalopathy (TSE) agents and other pathogens.

ISO 10993-1:2018
2018 08 17
Biological evaluation of medical devices — Part 1: Evaluation and testing within a risk management p...
Norm
ISO 10993-1:2009/Cor 1:2010
2010 06 04
Biological evaluation of medical devices — Part 1: Evaluation and testing within a risk management p...
Norm
ISO 10993-1:2009
2009 10 13
Biological evaluation of medical devices — Part 1: Evaluation and testing within a risk management p...
Norm
ISO 10993-1:2003
2003 07 28
Biological evaluation of medical devices — Part 1: Evaluation and testing
Norm
ISO 10993-1:1997
1997 12 11
Biological evaluation of medical devices — Part 1: Evaluation and testing
Norm
ISO 10993-1:1992/Cor 1:1992
1992 09 09
Biological evaluation of medical devices — Part 1: Guidance on selection of tests — Technical Corrig...
Norm
ISO 10993-1:1992
1992 04 23
Biological evaluation of medical devices — Part 1: Guidance on selection of tests
Norm
Expand